GRM2 and schizophrenia: However, in cognitive symptoms models, it improved MK-801-induced episodic memory deficits and reversed working memory impairments in NMDA receptor-deficient (Nr1neo−/−) mice, thus providing a piece of convincing evidence for mGluR2 PAMs cognition-enhancing effects in the genetic model of schizophrenia.